A detailed history of Aptus Capital Advisors, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 44,399 shares of PGEN stock, worth $35,075. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,399
Previous 44,399 -0.0%
Holding current value
$35,075
Previous $70,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 19, 2020

BUY
$3.5 - $6.2 $155,396 - $275,273
44,399 New
44,399 $155,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $164M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Aptus Capital Advisors, LLC Portfolio

Follow Aptus Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.